Due to the deleterious impact of aromatase inhibitors on the quality of life [16], it is currently discussed to promote adjuvant breast irradiation without hormonal therapy in the elderly with low-risk breast cancer [17, 18]. This evidence concerns the gene CYP19A1 and breast carcinoma.